This site is intended for Healthcare professionals only.
×

Cipla recalls 4,800 bottles of anti-HIV tablets from US


Cipla recalls 4,800 bottles of anti-HIV tablets from US

Drug major Cipla is recalling 4,800 bottles of Nevirapine extended-release tablets used for the treatment of human immunodeficiency virus (HIV) from the American market, according to a report by the US health regulator.

As per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is ‘failed dissolution specifications’.

Read Also: Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients

Nevirapine extended-release tablets, 400 mg in the 30-count bottle have been manufactured by Cipla at its Goa facility for Cipla USA Inc, it added.

The US health regulator has not yet classified the voluntary recall by the company, the report said.

The following two tabs change content below.
MD Team

MD Team

At Medical Dialogues, we are a team of young professionals strongly advocating of the transparency in the medical sector through the free flow of medical information, health and medical news. MD Team covers a variety of news related to the healthcare, pharma and medical device industry in India. Our team can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751


Source: PTI
0 comment(s) on Cipla recalls 4,800 bottles of anti-HIV tablets from US

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted